Koninklijke Philips | PHG - Des Atouts





Des Atouts Changement Date
Abbott USD 110.43B 23.72B 2026-03
Baxter International USD 19.85B 209M 2026-03
Becton, Dickinson and Co. USD 50.83B 4.01B 2026-03
Boston Scientific USD 44.35B 678M 2026-03
Danaher USD 83.54B 80M 2026-03
Demant DKK 39.07B 6.43B 2025-12
Dexcom USD 6.63B 293.4M 2026-03
Edwards Lifesciences USD 13.32B 376M 2026-03
Fresenius EUR 41.4B 1.07B 2025-12
General Electric Aerospace USD 127.67B 773M 2026-06
Getinge SEK 57.37B 6.55B 2026-06
Globus Medical USD 5.44B 136.79M 2026-03
GN Store Nord DKK 28.56B 671M 2026-03
Hitachi JPY 15.04T 356.53B 2026-03
Idexx Laboratories USD 3.39B 34.74M 2026-03
Insulet USD 2.99B 203.2M 2026-03
Integra LifeSciences USD 3.58B 24.28M 2026-03
Intuitive Surgical USD 20.88B 765.6M 2026-06
J&J USD 200.89B 1.68B 2026-03
Koninklijke Philips EUR 27.27B 4.38B 2026-03
Medtronic USD 91.48B 139M 2025-12
Philips EUR 27.27B 322M 2026-03
ResMed USD 8.78B 280.91M 2026-03
Smith & Nephew USD 10.69B 150M 2025-12
Steris USD 10.74B 145.8M 2026-03
Stryker USD 46.29B 1.55B 2026-03
Teleflex USD 6.78B 164.24M 2026-03
Terumo JPY 2.31T 55.3B 2026-03
Zimmer Biomet Holdings USD 22.72B 370.1M 2026-03